BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kaur R, Sodhi RK, Aggarwal N, Kaur J, Jain UK. Renoprotective effect of lansoprazole in streptozotocin-induced diabetic nephropathy in wistar rats. Naunyn Schmiedebergs Arch Pharmacol 2016;389:73-85. [PMID: 26475618 DOI: 10.1007/s00210-015-1182-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Gamil NM, Abd El Fattah MA, Ahmed MAE, Maklad YA, Gamal El Din AA, Eid NI. Lansoprazole enhances the antidiabetic effect of dapagliflozin in fortified diet-fed streptozotocin-treated diabetic rats. J Biochem Mol Toxicol 2020;34:e22451. [PMID: 31975531 DOI: 10.1002/jbt.22451] [Reference Citation Analysis]
2 Dik B, Coşkun D, Bahçivan E, Üney K. Potential antidiabetic activity of benzimidazole derivative albendazole and lansoprazole drugs in different doses in experimental type 2 diabetic rats. Turk J Med Sci 2021;51:1579-86. [PMID: 33641315 DOI: 10.3906/sag-2004-38] [Reference Citation Analysis]
3 Ying C, Dai J, Fan G, Zhou Z, Gan T, Zhang Y, Song Y, Zhou X. Ras-Related C3 Botulinum Toxin Substrate 1 Combining With the Mixed Lineage Kinase 3- Mitogen-Activated Protein Kinase 7- c-Jun N-Terminal Kinase Signaling Module Accelerates Diabetic Nephropathy. Front Physiol 2021;12:679166. [PMID: 34194338 DOI: 10.3389/fphys.2021.679166] [Reference Citation Analysis]